NCT07285434
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Biogenea Pharmaceuticals Ltd Thessaloniki, Macedonia, Greece
Clinical trial condition
Squamous Lung Cancer With FGFR1 Amplification
Explore clinical trials studying Squamous Lung Cancer With FGFR1 Amplification. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Squamous Lung Cancer With FGFR1 Amplification trial results
NCT01004224
- Conditions
- Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Advanced Solid Tumors With FGFR1 Amplication, Advanced Solid Tumors With FGFR2 Amplication, +19 more
- Locations
-
- Novartis Investigative Site Duarte, California, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Los Angeles, California, United States
- University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States